Pneumococcal Serotype-specific Opsonophagocytic Activity in Interleukin-1 Receptor-associated Kinase 4-deficient Patients: ERRATUM.

Accepted for publication December 21, 2020 From the *Department of Pediatrics, Naha City Hospital, Naha; †Infectious Disease Surveillance Center, National Institute of Infectious Diseases, Tokyo; ‡Toyama Institute of Health, Toyama; §Department of Pediatrics, St. Marianna University School of Medicine, Kawasaki; ¶Department of Neurology; ∥Department of Hematology and Oncology, Miyagi Children’s Hospital, Sendai; **Department of Pediatrics, Hiroshima University Graduate School of Biomedical and Health Sciences, Hiroshima; and ††Department of Child Health, Faculty of Medicine, University of Tsukuba, Tsukuba, Japan. This work was supported by the Japan Agency for Medical Research and Development (AMED) (under Grant Number JP20fk0108099h0002 to T.U.). The authors have no conflicts of interest to disclose. Address for correspondence: Tomoko Uehara, MD, Department of Pediatrics, Naha City Hospital, 2-31-1 Furujima, Naha-shi, Okinawa 902-8511, Japan. E-mail: tomoko_7979@hotmail.com. Pneumococcal Serotype-specific Opsonophagocytic Activity in Interleukin-1 Receptor-associated Kinase 4-deficient Patients